Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Virology|July 24, 2018
Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperinBénédicte Vanwalscappel, Takuya Tada, Nathaniel R LandauMbio|June 29, 2023
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)Ramanjit Kaur, Takuya Tada, Nathaniel Roy LandauProceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical modelTakuya Tada, Julia Minnee, Nathaniel R LandauJournal of Rural Medicine : JRM|July 18, 2022
Efficacy of peficitinib in two patients with rheumatoid arthritis on maintenance hemodialysisAkito Nishimura, Masayuki Tateiwa, Shuuitirou Tajima, et al.The FEBS Journal|May 16, 2021
MARCH8: the tie that binds to virusesTakuya Tada, Yanzhao Zhang, Hideaki Fujita, et al.JCI Insight|August 16, 2022
Directly injected lentiviral vector-based T cell vaccine protects mice against acute and chronic viral infectionTakuya Tada, Thomas D Norton, Rebecca Leibowitz, et al.Journal of Rural Medicine : JRM|July 14, 2023
Two cases of bilateral reverse shoulder arthroplasty performed in patients with rheumatoid arthritisTakuya Tada, Yuki Kobayashi, Misaki Watanabe, et al.Viruses|June 24, 2022
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal AntibodiesHao Zhou, Belinda M Dcosta, Nathaniel R Landau, et al.Biorxiv : the Preprint Server for Biology|February 23, 2022
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal AntibodiesHao Zhou, Takuya Tada, Belinda M Dcosta, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 InfectionTakuya Tada, Belinda M Dcosta, Julia Minnee, et al.Pageof 6